References
- Food and Drug Administration. [Website] Patient-reported outcome measures: use in medicinal product development to support labeling claims. Guidance for Industry. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed August 15, 2013.
- Schwartzberg L. Electronic patient-reported outcomes: the time is ripe for integration into patient care and clinical research. Am Soc Clin Oncol Educ Book. 2016;35:e89–e96. doi:10.14694/EDBK_158749
- Annegers JF. The epidemiology of epilepsy. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. 2nd. Baltimore:Williams & Wilkins; 1997:165–172.
- Hauser WA, Annegers JF. Epidemiology of acute symptomatic seizures. Epilepsy. 2009;87–91.
- Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. BMJ. 2002;324:1193–1194. doi:10.1136/bmj.324.7347.1193
- Coons SJ, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force Report. Value Health. 2009;12:419–429. doi:10.1111/j.1524-4733.2008.00470.x
- Robling MR, Ingledew DK, Greene G, et al. Applying an extended theoretical framework for data collection mode to health services research. BMC Health Serv Res. 2010;10:180. doi:10.1186/1472-6963-10-180
- Hunt SD. Modern Marketing Theory. Cincinnati: South-Western Publishing; 1991.
- Degerliyurt K, Gunsolley JC, Laskin DM. Informed consent: what do patients really want to know? J Oral Maxillofac Surg. 2010;68(8):1849–1852. doi:10.1016/j.joms.2010.04.004
- IBM Corp. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp; 2015.
- US Food and Drug Administration. Guidance for industry: electronic source data in clinical investigations; 2013. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM328691.pdf. Accessed December 16, 2019.
- Zbrozek A, Hebert J, Gogates G, et al. Validation of electronic systems to capture patient-reported outcome (PRO) data – recommendations for clinical trial teams: report of the ISPOR ePRO systems validation task force. Value Health. 2013;16:480–489. doi:10.1016/j.jval.2013.04.002
- Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. doi:10.1200/JCO.2015.63.0830
- Gwaltney CJ, Shields A, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health. 2008;11(2):322–333.9. doi:10.1111/j.1524-4733.2007.00231.x
- Kušec S, Orešković S, Škegro M, Korolija D, Bušić Ž, Horžić M. Improving comprehension of informed consent. Patient Educ Couns. 2006;60(3):294–300. doi:10.1016/j.pec.2005.10.009
- Feudtner C. What are the goals of patient education? West J Med. 2001;174:173–174. doi:10.1136/ewjm.174.3.173
- Kaur G, Smyth RL, Williamson P. Developing a survey of barriers and facilitators to recruitment in randomized controlled trials. Trials. 2012;13:218. doi:10.1186/1745-6215-13-218
- Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin. 2009;25:929–942. doi:10.1185/03007990902774765
- Ahmed S, Berzon RA, Revicki DA, et al. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care. 2012;50:1060–1070. doi:10.1097/MLR.0b013e318268aaff